New inhaled drug enters first human tests
NCT ID NCT07285122
Summary
This is the first study in humans to test the safety of a new inhaled drug called RB042. Researchers will give single and multiple doses to 90 healthy adults, including some who smoke, to check for side effects and see how the body handles the drug. The main goal is to determine if RB042 is safe enough to test further in people with diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.